Citatepine

This classification denotes a dopamine antagonist with the molecular formula C20H18N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 92S48G7U0W, chemically known as 2,3,4,5-tetrahydro-3-methyl-1h-dibenzo(2,3:6,7)thiepino(4,5-d)azepine-7-carbonitrile. but generally known as citatepine, which bears US NIH Compound Identifier 193991. European Medicines Agency schedules Citatepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07486MIG. The term CITATEPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). CITATEPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule citatepine under HS 29349990 and SITC 51579. As of Q4 2014, CITATEPINE remains the US FDA Preferred Term for this commodity. Citatepine bears US NLM identifiers UMLS ID C2699334 and NCI Concept Code C77570. SMILES: S1C2C(C3=C(CCN(CC3)C)C3C1CCCC3)CC(CC2)C#N.